FindTrial
Sign In

Oxidized Low-Density Lipoprotein (Ox-LDL) Detection Kit (Chemiluminescence Immunoassay, CLIA)?

Clinical Trial for the Oxidized Low-Density Lipoprotein (Ox-LDL) Detection Kit (Chemiluminescence Immunoassay)?

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500108260
Enrollment
Unknown
Registered
2025-08-27
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease, atherosclerosis, and related conditions (e.g., heart failure, cardiovascular and cerebrovascular diseases).

Interventions

Gold Standard:The concentration of Oxidized Low-Density Lipoprotein (Ox-LDL) in serum
Index test:OX-LDL

Sponsors

Chengdu Pidu District Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 90 Years

Inclusion criteria

Inclusion criteria: 1.Individuals who may potentially undergo examination: This includes persons with coronary heart disease, atherosclerosis, and related conditions (e.g., heart failure, cardiovascular and cerebrovascular diseases) accompanied by clinical symptoms, and whose leftover serum samples—collected after diagnosis and testing in relevant hospital departments—meet the preservation criteria specified in this protocol for intended disposal.

Exclusion criteria

Exclusion criteria: 1.Samples exhibiting severe hemolysis, lipemia, jaundice, or other unidentified precipitates and impurities.

Design outcomes

Primary

MeasureTime frame
Ox-LDL;—

Countries

China

Contacts

Public ContactKong

Chengdu Pidu District Hospital of Traditional Chinese Medicine

13540057386@qq.com+86 28 8792 0858

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026